|
¡¡
Pre-clinical study
Pharmaceutical study
¡ï
Synthesis and Structure
Elucidation of New Compounds
¡ï Quality specification study
¡ï
Stability study
¡¡
Pharmacology and toxicology study
¡ï
Bioactivity screening of new
compounds
¡ï Primary pharmacodynamics study
¡ï
General Pharmacology study
¡ï Acute/single dose toxicity study
¡ï Repeated dose toxicity study
¡ï Study of hypersensitive, hemolytic and
topical irritative reactions
¡ï Study
of Pharmacodynamics, toxicity and pharmacokinetics
change caused
by the interactions amongst multiple
components in the combination products.
¡ï
Mutagenicity study
¡ï
Reproductive toxicity study.
¡ï Pre-clinical pharmacokinetics study.
Our strengths:
1, Familiar with the relevant regulations and
technical guidelines
2, Make rational study protocols in view of the
characteristics of drugs to meet
the requirements
of SFDA
3, Inspect the experimental process regularly to ensure
a smooth completion.
4, Examine and improve the experimental reports to
ensure they can meet the
requirements of SFDA.
Contact:
Pharmaceutical study: 86-10-68180921, 86-13501010127
Pharmacology and toxicology study: 86-10-68180102,
86-13911785216
¡¡
|
